A review of the scientific literature as it pertains to Gulf War illnesses.
Golomb, Beatrice Alexandra.
A review of the scientific literature as it pertains to Gulf War illnesses. Vol. 2, Pyridostigmine bromide / Pyridostigmine bromide Beatrice Alexandra Golomb. - xxxviii, 385 pages : illustrations ; 26 cm - Gulf War illnesses series .
"National Defense Research Institute." "This work ... was carried out jointly by RAND Health's Center for Military Health Policy Research and the Forces and Resources Policy Center of the National Defense Research Institute"--Preface.
Includes bibliographical references (p. 303-385).
The United States and its allies in the Persian Gulf War (PGW) knew that Iraq had used nerve agents and chemical weapons in its previous conflicts and so took steps to protect their troops. Pyridostigmine bromide (PB) was distributed as a pretreatment that would enhance the effectiveness of postexposure treatments in the event that the nerve agent soman was used. This report examines the role that PB played in the ongoing chronic health problems documented in PGW veterans. After careful examination of the known effects of PB on the central and peripheral nervous systems, the author finds the evidence consistent with a possible role for PB as a contributor to the health complaints of some PGW veterans and calls for immediate attention in the form of additional investigation to clarify the role of PB.
0833026771
RAND/MR-1018/2-OSD
$30.00
98031679
Biological weapons--Health aspects.
Chemical agents (Munitions)--Health aspects.
Persian Gulf syndrome--United States.
Persian Gulf War, 1991--Health aspects--United States.
Persian Gulf War, 1991--Veterans--Diseases--United States.
Veterans--Diseases--United States.
Electronic books.
RB152.7 / .R482 1999
A review of the scientific literature as it pertains to Gulf War illnesses. Vol. 2, Pyridostigmine bromide / Pyridostigmine bromide Beatrice Alexandra Golomb. - xxxviii, 385 pages : illustrations ; 26 cm - Gulf War illnesses series .
"National Defense Research Institute." "This work ... was carried out jointly by RAND Health's Center for Military Health Policy Research and the Forces and Resources Policy Center of the National Defense Research Institute"--Preface.
Includes bibliographical references (p. 303-385).
The United States and its allies in the Persian Gulf War (PGW) knew that Iraq had used nerve agents and chemical weapons in its previous conflicts and so took steps to protect their troops. Pyridostigmine bromide (PB) was distributed as a pretreatment that would enhance the effectiveness of postexposure treatments in the event that the nerve agent soman was used. This report examines the role that PB played in the ongoing chronic health problems documented in PGW veterans. After careful examination of the known effects of PB on the central and peripheral nervous systems, the author finds the evidence consistent with a possible role for PB as a contributor to the health complaints of some PGW veterans and calls for immediate attention in the form of additional investigation to clarify the role of PB.
0833026771
RAND/MR-1018/2-OSD
$30.00
98031679
Biological weapons--Health aspects.
Chemical agents (Munitions)--Health aspects.
Persian Gulf syndrome--United States.
Persian Gulf War, 1991--Health aspects--United States.
Persian Gulf War, 1991--Veterans--Diseases--United States.
Veterans--Diseases--United States.
Electronic books.
RB152.7 / .R482 1999